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A B S T R A C T
A simple and straightforward method for the determination of dolasetron mesylate (DM) in aqueous solution
was developed based on the ﬂuorescence quenching of 3-Mercaptopropionic acid (MPA) capped CdS quantum
dots (QDs). The structure, morphology, and optical properties of synthesized QDs were characterized by using
UV-Vis absorption spectroscopy, ﬂuorescence spectroscopy, transmission electron microscopy (TEM) and
dynamic light scattering (DLS) measurements. Under the optimum conditions, the MPA-CdS QDs ﬂuorescence
probe oﬀered good sensitivity and selectivity for detecting DM. The probe provided a highly speciﬁc selectivity
and a linear detection of DM in the range of 2–40 µg/mL with detection limit (LOD) 1.512 µg/mL. The common
excipients did not interfere in the proposed method. The ﬂuorescence quenching mechanism of CdS QDs is also
discussed. The developed sensor was applied to the quantiﬁcation of DM in urine and human serum sample
with satisfactory results.
1. Introduction
Dolasetron mesylate (DM, Fig. 1) is an antinauseant and antiemetic
agent. It is a highly speciﬁc and selective serotonin subtype 3 (5-HT3)
receptor antagonist both in vitro and in vivo.
DM is currently being used for the management of nausea and
vomiting associated with cancer chemotherapy, radiotherapy and
surgical procedures [1,2]. Its main eﬀect is to reduce the activity of
the vagus nerve that activates the vomiting center in the medulla
oblongata. Dolasetron breaks down slowly, staying in the body for a
long time. One dose usually lasts 4–9 h and is usually administered
once or twice daily. This drug is metabolized in the liver and removed
from the body by the kidneys. It is also sometimes used as an
antiemetic (anti-vomiting medication) in veterinary medicine for dogs
and cats. Dolasetron is a well-tolerated drug with few side eﬀects.
Headache, dizziness, and constipation are the most commonly reported
side eﬀects associated with its use. However, the FDA has recently
issued a drug communication, stating that the injection form of
dolasetron, a 5HT3 agonist, should no longer be used in adult or
pediatric patients with chemotherapy-induced nausea and vomiting
(CINV). Dolasetron injection can increase the risk of developing
torsade de pointes, a potentially fatal abnormal heart rhythm [3,4].
Therefore, the quantiﬁcation of DM is essential in biomedical samples.
So far, very few methods have been developed for the analysis of
DM in human plasma and urine. Previous methods based on gas
chromatography–mass spectrometry (GC–MS) [5] and high perfor-
mance liquid chromatography (HPLC) [6–8] suﬀered from poor
sensitivity and endogenous interferences or complicated derivatization
procedures. In addition, these methods have some limitations like use
of expensive instruments, long operation time and reagents required
not easily available in many laboratories. Therefore, it is necessary to
develop a fast, simple, sensitive, selective and straightforward method
for analysis of DM in human urine and blood serum.
Nowadays, ﬂuorescence-based sensors have attracted much atten-
tion due to its simple operation, low cost, selectivity, and high
sensitivity and thus can be used for real sample analysis. Mostly
conjugated polymers, organic ﬂuorescent molecules, ﬂuorescent dyes,
semiconducting nanoparticles and ﬂuorescent proteins are used as
ﬂuorescence sensors. Among them semiconducting nanocrystals or
quantum dots (QDs) have attracted much attention of researchers
towards development of sensors. QDs possess outstanding optical
properties, such as broad absorption spectra, narrow and symmetric
size-tunable emission, high quantum yields, and high photobleaching
stability, which make them advantageous over traditional ﬂuorophores
for bioimaging and biosensing applications [9,10]. In 1998, Bruchez
and co-workers [11] and Chan and Nie [12] were the ﬁrst to recognize
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the applications of QDs for biology. So far, many ﬂuorescence-based
methods have been developed by using semiconducting QDs for
analysis of ions [13–16], bioimaging [17–21], biosensing [22–25],
pharmaceutical analysis [26–31] and explosives [32].
Chen et al. [25] developed a chemiluminescence probe based on
hydrogen peroxide–sodium hydrogen carbonate-CdSe/CdS QDs sys-
tem for the determination of L-ascorbic acid in human serum.
The chemiluminescence intensity and the concentration of
L-ascorbic acid have a good linear relationship in the ranges of
1.0×10−7−1.0×10−4 mol/L and detection limit (LOD) for L-ascorbic
acid is 6.7×10−9 mol/L. Hou et al. [23] reported a ﬂuorescence sensor
for the determination of sparﬂoxacin (SPFX) based on ﬂuorescence
quenching of CdSe/CdS QDs at 556 nm wavelengths. The ﬂuorescence
quenching intensity of QDs is linearly proportional to the concentration
of SPFX ranging from 0.5 µg/mL to 40 µg/mL, with LOD of 0.1391 µg/
mL. Further this method was applied for the determination of SPFX in
pharmaceutical tablets and milk samples. Liang et al. [27] developed a
ﬂuorescence probe for spironolactone detection based on the ﬂuores-
cence quenching of CdSe QDs with good linearity range between
2.5 µg/mL and 700 µg/mL and LOD was 0.2 µg/mL. Fluorescence
quenching probe for detection of dopamine has been reported by using
functionalized CuInS2 QDs [33]. The turn-on ﬂuorescent biosensor for
herring sperm DNA (hsDNA) detection was designed by Shen et al.
[22] based on hsDNA-induced ﬂuorescence enhancement of Sm3+
modulated glutathione (GSH)-capped CdTe QDs. Also, there is devel-
opment of turn-on ﬂuorescence sensor for ATP detection based on
cysteamine capped CdS QDs in aqueous solution with very LOD (17
μM), which is applied to determine ATP in spiked urine samples [34].
The possible sensing mechanism was based on the charge-charge
interaction concurrent with the hydrogen bonding between ATP and
protonated amine group on the Cys-CdS QDs surface. Recently, we
have presented a novel turn-on ﬂuorescence sensor for determination
of D-penicillamine (D-PA) in pharmaceutical formulation by CdS QDs
[29]. The key sensing mechanism of ﬂuorescence enhancement of QDs
was attributed to the passivation of the trap states of MPA-CdS QDs
through the binding of mercapto group of D-PA with Cd2+ in core shell.
Very recently, a Förster resonance energy transfer (FRET)-based
ﬂuorescence detection of ascorbic acid (AA) has been developed using
CdS QDs and diphenylcarbazide (DPC). The present FRET-based CdS
QD probe showed an unprecedented LOD of 2 nM with a dynamic
range of 60–300 nM for AA detection [31].
Up to date, very few reports have been available on QDs-based
sensors for pharmaceutical and biomedical analyses. Therefore, there is
very vital need to develop QDs-based sensors for biomedical analysis.
As per our knowledge, this is the ﬁrst report on CdS QDs-based
ﬂuorescence probe for the determination of DM in real samples. In this
report, we have proposed detection of DM based on ﬂuorescence
quenching of CdS QDs. Here, the ﬂuorescence intensity of CdS QDs
goes on decreasing with successive addition of DM. The sensing
mechanism toward the selective detection of DM is proposed and
systematically discussed. Moreover, the feasibility of the proposed
probe is checked for the determination of DM in human urine
and blood serum. The both urine and serum samples were obtained
from the ﬁrst author of this manuscript and collected in Primary
Health Center Shivaji University, Kolhapur, India.
2. Experimental
2.1. Chemicals
All chemicals which were used for synthesis of QDs are of analytical
reagent grade and used as received without further puriﬁcation.
Cadmium chloride (CdCl2·H2O) and sodium sulﬁde (Na2S) were
procured from s d Fine-CHEM Ltd. (Mumbai, India). 3-
Mercaptopropionic acid (MPA), di-potassium hydrogen orthopho-
sphate (K2HPO4) and potassium dihydrogen orthophosphate dihydrate
(KH2PO40·2H2O) for phosphate buﬀer preparation were purchased
from Spectrochem Chemicals (Mumbai, India). The stock solution of
DM was prepared in doubly distilled water which was purchased from
Sigma-Aldrich (Mumbai, India). Solutions of all coexisting substances
were prepared in the double distilled water and stored at room
temperature.
2.2. Instrumentations
Fluorescence measurement of solutions was made with PC based
Spectroﬂuorophotometer (JASCO Model FP-8300, Japan) equipped
with Xenon lamp source and 1.0 cm quartz cell. Both excitation and
emission slits were ﬁxed at 5 nm with medium sensitivity. The
absorption spectrum was recorded on ultraviolet-visible near infrared
(UV-Vis-NIR) spectrophotometer (Specord 210, analytic jena) with
1.0 cm quartz cell. Particle size of CdS QDs was measured by using
transmission electron microscopy (TEM) (TEM, FEI Tecnai 300) and
dynamic light scattering (DLS) (Malvern Instruments Ltd., UK). The
ﬂuorescence life time of CdS QDs was measured on time resolved
ﬂuorescence spectrometer (Horiba’s Jobin-Yv on- IBH). High-speed
centrifuge model C-24 BL (REMI Instrument Ltd, Mumbai, India) was
applied for centrifugation operation.
2.3. Synthesis of functionalized CdS QDs (MPA-CdS QDs)
Water soluble functionalized CdS QDs were synthesized by the
method described in our previous report [29]. In brief, the 20 mL of
0.1 mol/L CdCl2·H2O solution was dropped into the 5.0 mL of 1.0 mol/
L MPA solution slowly with constant stirring at room temperature.
Then pH was adjusted at 6.0–7.0 by the dropwise addition of 0.1 mol/L
NaOH solution followed by 10 mL of 0.1 mol/L Na2S. Under vigorous
stirring, a clear yellowish suspension was obtained, which clearly
indicated that formation of MPA-CdS QDs. After stirring for 12 h,
the mixture was diluted to 100 mL with double distilled water. The
concentration of prepared CdS QDs was 0.02 mol/L, which was
determined as per the concentration of S2− added.
2.4. Fluorescence measurement
Initially, 100 µg/mL of standard DM solution was prepared by
dissolving 5 mg pure DM with double distilled water in a 50 mL
volumetric ﬂask. For the determination of DM by CdS QDs, we adopted
the following procedure: to a 10 mL volumetric ﬂask, 2.0 mL CdS QDs
solution having concentration of 5×10–4 mol/L was added and then
known volume of standard DM solution was added into it. Finally, the
mixture was diluted up to the mark with double distilled water and
mixed thoroughly. After 5.0 min, diluted solution was transferred into
the quartz cell and the ﬂuorescence intensity was measured at
λex=370 nm with a slit width of 5.0 nm for excitation and emission at
medium intensity. Similar procedure was used for determination of
DM in human urine and blood serum by standard addition method.
Fig. 1. Structure of DM.
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2.5. Selectivity
The selectivity of the proposed method for DM was studied by
performing the following procedure. Stock solutions of various sub-
stances and some common ions were prepared by dissolving pure
substances and salts in deionized water, respectively. To a standard
volumetric ﬂask (10 mL), 2.0 mL of CdS QDs solution, DM and known
volume of standard solutions of interfering substances (double con-
centration) were added. Then the solutions were diluted with water to
10 mL and mixed thoroughly. After 5.0 min, the ﬂuorescence was
measured.
2.6. Real sample analysis
A urine sample from a healthy volunteer was collected and ﬁltered
through a Whatman No. 42 ﬁlter paper. Then the ﬁltered urine sample
was diluted to 100 times with double distilled water. Diﬀerent
concentrations of standard DM solution were added to the diluted
urine samples to prepare spiked samples.
Blood sample was collected from the healthy volunteer, centrifuged
at 4500 rpm for 10 min and kept for settling for 3 h. From centrifuged
sample, serum was isolated and 1 mL of serum was further diluted
to 10 mL. Diﬀerent concentrations of standard DM solution were
added to the diluted serum samples to prepare spiked samples.
3. Results and discussion
3.1. Characterization of functionalized CdS QDs
The optical properties of synthesized MPA-CdS QDs were char-
acterized and the results are shown in Fig. 2. The synthesized QDs
showed a narrow and symmetrical emission spectrum, suggesting that
the prepared CdS QDs were nearly homogenous and monodisperse
[35]. The particle size of QDs was measured by HR-TEM and DLS and
the results are shown in Fig. 3. From the DLS study, the average
particle size was found to be 3.86 nm. Moreover, the particle size of the
prepared CdS QDs was calculated from absorption maximum of the
UV-Vis spectrum according to the literature [36] and found around
2.50 nm.
3.2. Fluorescence quenching study
In the present work, the interaction between MPA-CdS QDs and
DM was systematically studied based on the ﬂuorescence change of
MPA-CdS QDs induced by DM. It could be seen from Fig. 4A that there
was quenching of the ﬂuorescence intensity of CdS QDs with increasing
concentration of DM. Furthermore, Fig. 4B shows there was a good
linear relationship between F0/F (F and F0 are ﬂuorescence intensity of
QDs with and without DM) and the DM concentration ranging from
2 µg/mL to 40 µg/mL. The corresponding linear correlation coeﬃcient
(R2) was 0.9989 and the LOD was 1.512 µg/mL. LOD was calculated by
equation, 3σ/k, where σ is the standard deviation of the y-intercept of
regression line and k is the slope of the calibration graph [37].
3.3. Possible sensing mechanism
The QDs have been regarded as good ﬂuorophores for diﬀerent
analytes because of their unique optical properties and surface
modiﬁcation. The ﬂuorescence of QDs results from radiative recombi-
nation of photo-induced electron and hole located at the conduction
band and valence band, respectively. Therefore, QDs have been used as
a good sensor based on ﬂuorescence enhancement and ﬂuorescence
quenching by analytes. Based on ﬂuorescence enhancement
[23,29,34,38] and ﬂuorescence quenching [13,24,27,28,33,39,40],
many methods have been developed for detection of diﬀerent analytes.
There are two kinds of ﬂuorescence quenching: dynamic quenching
and static quenching. Quenching mechanisms include inner ﬁlter
eﬀects, nonradiative recombination pathways, electron transfer pro-
cesses, and ion binding interaction. Liu et al. [33] have developed
functionalized CuInS2 QDs as a near-infrared ﬂuorescence probe for
the determination of dopamine based on ﬂuorescence quenching of
QDs due to the strong interaction of vicinal diol groups on the surface
of CuInS2 QDs with dopamine molecules by covalent bonding to form
ﬁve membered cyclic boronate ester, which leads to an increase in
thickness of the surface capping layer of QDs. Koneswaran and
Narayanaswamy [28] described the quenching of L-cysteine capped
CdS/ZnS QDs by vitamin B6 based on nonradiative recombination of
excited electrons and holes which is attributed to the eﬀective electron
transfer from QDs to vitamin B6. Very recently, there has been one
report on determination of 2,4,6-trinitrotoluene (nitro-explosive)
based on ﬂuorescence quenching using CdTe(S)@PAM QDs [32]. The
ﬂuorescence quenching of QDs was due to resonance energy transfer,
which was conﬁrmed by the ﬂuorescence life time measurement and
electron transfer from QDs core to 2,4,6-trinitrotoluene.
To explore the mechanism of ﬂuorescence quenching of MPA
capped CdS QDs by the successive addition of DM, we used diﬀerent
analytical techniques such as ﬂuorescence spectroscopy, UV–Vis
absorption spectroscopy and ﬂuorescence life time measurement.
Fluorescence quenching spectra of CdS QDs before and after successive
addition of DM show that there was no signiﬁcant shift in emission
wavelength (Fig. 4A), which confers that there is no change on the
surface of CdS QDs and ﬂuorescence quenching may be due to either
electron transfer from QDs to DM [28] or resonance energy transfer
[32]. Moreover, there is no signiﬁcant change in absorption spectra of
QDs before and after addition of DM (Fig. 5), which conﬁrms that there
is no aggregation of CdS QDs after addition of DM [28]. Here, DM with
indole structure could serve as an eﬃcient electron acceptor due to
electron withdrawing group in its vicinity. Hence, the ﬂuorescence
quenching of QDs may be due to nonradiative recombination of excited
electrons and holes [28]. Further, CdS QDs are electron donor, and
electron transfer from the QDs cores to the DM may be another cause
of ﬂuorescence quenching [32]. The type of ﬂuorescence quenching of
the present system was also investigated by the ﬂuorescence life time
measurements. It can be seen from Fig. 6 that there is no change in the
ﬂuorescence life time of QDs (around 5.48 ns) in absence and presence
of diﬀerent concentrations of DM. This result suggests that the
mechanism of the quenching is static quenching rather than dynamic
quenching. Moreover, it is also supported using Stern–Volmer equa-
tion,
F /F = 1 + K [Q]0 SV
where F and F0 are the ﬂuorescence intensities of the QDs with and
Fig. 2. (A) UV–Vis absorption spectrum at λmax=368 nm and (B) emission spectrum at
λmax=571 nm (excited at 370 nm) of MPA-CdS QDs (1×10
−4 mol/L) in aqueous colloidal
solution.
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without DM, [Q] is the concentration of quencher (DM) and Ksv is the
Stern–Volmer quenching rate constant. A very good linear relationship
was observed in the concentration range of 2 µg/mL to 40 µg/mL of
DM. The Stern–Volmer quenching constant was found to be
3.84×103 dm3/mol, and linear correlation coeﬃcient (R2) was
0.9989. For dynamic type quenching, the quenching constant is always
less than 200 dm3/mol while for static type of quenching it is greater
than 200 dm3/mol; therefore, the present quenching process is static
type (Ksv > 200 dm
3/mol) [24,41]. In static quenching, formation of
ground state complex takes place between ﬂuorophores and quencher.
Conversely, there is a possibility of ground state complex formation
between the QDs and DM due to electrostatic interaction between them
and it may be the one more cause of ﬂuorescence quenching. The
schematic illustration of the plausible quenching mechanism is shown
in Scheme 1.
3.4. Selectivity of the sensor
To evaluate the selectivity of the CdS QDs as a ﬂuorescent
quenching probe for DM, the ﬂuorescence response of the QDs was
investigated towards other biomolecules and some ions, having con-
Fig. 3. (A) HR-TEM image and (B) particles size distribution of the MPA-CdS QDs measured by DLS.
Fig. 4. (A) Fluorescence (excited at 370 nm) quenching spectra of MPA-CdS QDs (1×10−4 mol/L) upon addition of diﬀerent concentrations of DM from 2 µg/mL to 50 µg/mL and (B)
the plot of (F0/F) versus concentrations of DM from 2 µg/mL to 40 µg/mL.
Fig. 5. UV–Vis absorption spectra of MPA-CdS QDs (5×10−5 mol/L) upon addition of
diﬀerent concentrations of DM (0, 10, 20 and 40 µg/mL).
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centrations of 40 µg/mL and 80 µg/mL, respectively. As shown in
Figs. 7 and 8, only DM resulted in signiﬁcant ﬂuorescence quenching of
the CdS QDs. It was found that the common interfering substances like
sucrose, glucose, maltose, dextrose, starch, PEG, SDS, K+, Na+ and urea
did not aﬀect the ﬂuorescence intensity even at high concentration.
However, there were some eﬀects of coexisting substances on the
ﬂuorescence of CdS QDs, but it was not much signiﬁcant in our
proposed method. The results revealed that the proposed method can
be applied to the detection of DM in human urine and blood serum
samples.
3.5. Comparison with other methods
There are only few methods developed for the determination of DM
based on diﬀerent analytical techniques. Most of them require sophis-
ticated and expensive instruments, costly chemicals, and operation
seems to be complex prior to analysis. For comparison, analytical
performances of diﬀerent methods for the determination of DM are
summarized in Table 1. The proposed method based on ﬂuorescence
quenching of QDs is superior because of simple experimental proce-
dure, easy synthesis of QDs, short analysis time and no need for costly
solvents. Therefore, the proposed method is the best alternative to
determine the amount of DM in real samples.
3.6. Analytical applications of the proposed sensor
To conﬁrm the feasibility of the proposed ﬂuorescence sensor,
recovery experiments were performed to determine the concentration
of DM in real human urine and blood serum samples of a healthy
volunteer using standard addition method and the results are shown in
Table 2. The relative standard deviation (RSD) was lower than 1%, and
the average recoveries of DM in the real sample were 99%–101%. The
excipients in real samples did not interfere with the determination.
These results conﬁrm that the proposed sensor is reliable for the
practical use.
Fig. 6. Fluorescence decay proﬁle of MPA-CdS QDs (1×10−4 mol/L) upon addition of
diﬀerent concentrations of DM (0, 10 and 20 µg/mL).
Scheme 1. Schematic illustration of plausible ﬂuorescence quenching mechanism of CdS QDs.
Fig. 7. Fluorescence spectra of the MPA-CdS QDs (1×10−4 mol/L) solution in the
presence and absence of DM (40 µg/mL) and several coexisting substances (80 µg/mL).
Fig. 8. Fluorescence intensity [1–(F0/F)] of the MPA-CdS QDs (1×10
−4 mol/L) solution
in the presence and absence of DM (40 µg/mL) and several coexisting substances (80 µg/
mL).
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4. Conclusion
A ﬂuorescence sensor was developed for DM sensing in aqueous
solution. The key sensing mechanism of ﬂuorescence quenching was
based on the nonradiative recombination of electron and hole. The
quenching of ﬂuorescence intensity of QDs with an increasing con-
centration of DM was in the linear range of 2 −40 µg/mL with LOD
being 1.512 µg/mL, indicating that this sensor can be used to detect
DM in real sample. The proposed method was successively applied to
the detection of DM in human urine and blood serum sample with
satisfactory results.
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